1. Home
  2. Live Updates
  3. Biohaven pharmaceutical

Live Breaking News & Updates on Biohaven Pharmaceutical

Stay updated with breaking news from Biohaven pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SixPeaks, a new obesity biotech, starts up with an option to sell to AstraZeneca

BioPharma ....

United Kingdom , Sixpeaks Bio , Alex Mayweg , Philip Larsen , Versant Ventures , Switzerland Based Ridgeline Discovery , Biohaven Pharmaceutical , Maverick Therapeutics ,

Motley Fool: Investors may consider Pfizer as good medicine

Motley Fool: Investors may consider Pfizer as good medicine
spokesman.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from spokesman.com Daily Mail and Mail on Sunday newspapers.

United States , Cedar Hills , Judd Kahn , John Heins , Erin Bellissimo , Whitney Tilson Wiley , Ronaldw Chan Wiley , Santos Wiley , Marka Cooper , Bruce Greenwald , Lessons From The World Top Fund Managers , Michael Batnick Bloomberg , Biohaven Pharmaceutical , Motley Fool , Best Investors , Their Worst , Michael Batnick , Bloomberg Press , From Graham , Tano Santos , Value Investors , Lessons From , Top Fund , Value Investing , Best Investors Beat , Whitney Tilson ,

As ALS research booms, one treatment center finds itself in the spotlight

BioPharma ....

United States , University Of Washington Medical Center , Sabrina Paganoni , Jackie Whitesell , Michael Weiss , Michael Hayden , Clene Nanomedicine , Jen Scalia , Josh Cohen , Rob Etherington , Justin Klee , Jeremy Shefner , Seanm Healey , Rudy Tanzi , Joe Biden , Amylyx Cohen , Mark Reedy , Clene Etherington , Robert Brown , Nick Marchionda , Sean Healey , Nivedita Jerath , Amylyx Pharmaceuticals , Our Department , Washington University School Of Medicine , Apellis Pharmaceuticals ,

Factbox-How Pfizer is fortifying for growth beyond COVID products

The company on Wednesday forecast revenue from its COVID-19 vaccine and treatment to be $8 billion in 2024, a far cry from the $57 billion in 2022. In March, Pfizer announced a $43 billion acquisition of drugmaker Seagen to bring into its fold four approved cancer therapies. Last year, the company struck an $11.6 billion deal for migraine drug maker Biohaven Pharmaceutical Holding and bought Global Blood Therapeutics for $5.4 billion, adding sickle cell disease treatment Oxbryta to its pipeline. ....

United States , Khushi Mandowara , Sriraj Kalluvila , Manas Mishra , Damien Conover , Caribou Sciences , Biohaven Pharmaceutical Holding , Global Blood Therapeutics , Akero Therapeutics , United Kingdom , Global Blood Therapeutics , Biohaven Pharmaceutical Holding , Biohaven Pharmaceutical , Cost Cutting , Aribou Sciences And Akero Therapeutics ,

3 Healthcare Stocks With Healthy Dividends

These pharmaceutical companies all combine relatively high dividends with safe payout ratios. ....

Arena Pharmaceuticals , Drug Administration , Biohaven Pharmaceutical , Global Blood Therapeutics ,